Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria

Infection and Immunity

Volumn 64, Issue 5, 1996, Pages 1666-1671

  Lanar, David E ^a   Tine, John A ^b   De Taisne, Charles ^c   Seguin, Matthew C ^a   Cox, William I ^b   Winslow, Joseph P ^b   Ware, Lisa A ^a   Kauffman, Elizabeth B ^b   Gordon, Daniel ^a   Ripley Ballou, W ^a   Paoletti, Enzo ^b   Sadoff, Jerald C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Virogenetics Corporation   (United States)

^c Pasteur Merieux Serums et Vaccins   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; PROTOZOAL PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; IMMUNIZATION; IMMUNOGENICITY; MALARIA; MALARIA CONTROL; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SPOROZOITE; SUPPRESSOR CELL; VACCINIA VIRUS; VIRUS ATTENUATION; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, PROTOZOAN; HUMANS; IMMUNITY, CELLULAR; MALARIA; MICE; MICE, INBRED BALB C; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; T-LYMPHOCYTE SUBSETS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 9244224607     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. + cytotoxic T cells. J. Exp. Med. 172:1083-1090.
2. Ballou, W. R., S. L. Huffman, J. A. Sherwood, M. R. Hollingdale, F. A. Neva, W. T. Hockmeyer, D. M. Gordon, I. Schneider, R. A. Wirtz, J. F. Young, G. F. Wasserman, P. Reeve, C. L. Diggs, and J. D. Chulay. 1987. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1:1277-1281.
3. Brochier, B., M. P. Kieny, F. Costy, P. Coppens, B. Bauduin, J. P. Lecocq, B. Languet, G. Chappuis, P. Desmettre, K. Afiademanyo, R. Libois, and P.-P. Pastoret. 1991. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature (London) 354:520-522.
4. Brockmeier, S. L., K. M. Lager, J. Tartaglia, M. Riviere, E. Paoletti, and W. L. Mengeling. 1993. Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses. Vet. Microbiol. 38:41-58.
5. Brunner, K. T., J. Mauel, J. C. Cerotinni, and B. Chapuis. 1968. Quantitative assay of the lytic action of immune lymphoid cells on Cr-labelled allogencic target cells in vitro, inhibition by isoantibody and by drugs. Immunology 14:181-196.
6. Chakrabarti, S., M. Robert-Guroff, F. Wong-Staal, R. C. Gallo, and B. Moss. 1986. Expression ot the HTLV-III envelope gene by a recombinant vaccinia virus. Nature (London) 320:535-540.
7. Coupar, B. E. H. M. E. Andrew, G. W. Both, and D. B. Boyle. 1986. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur. J. Immunol. 16:1479-1487.
8. Cox, W. I., J. Tartaglia, and E. Paoletti. 1992. Poxvirus recombinants as live vaccines, p. 123-162. In M. M. Binns and G. L. Smith (ed.), Recombinant poxviruses CRC Press, Inc., Boca Raton, Fla
9. Cox, W. I., J. Tartaglia, and E. Paoletti. 1993 Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein. Virology 195:845-850
10. Cremer, K. J., M. Mackett, C. Wohlenberg, A. L. Notkins, and B. Moss. 1984. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228:737-740.
11. Deubel, V., R. M. Kinney, J. J. Esposito, C. B. Cropp, A. V. Vorndam, T. P. Monath, and D. W. Trent. 1988. Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J Gen Virol. 69:1921-1929.
12. Egan, J. E., J. L. Webster, W. R. Ballon, M. R. Hollingdale, W. R. Majarian, D. M. Gordon, W. L. Maloy, S. L. Hoffman, R. A. Wirtz, I. Schneider, G. R. Woollet, J. F. Young, and W. T. Hockmeyer. 1987 Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 236:453-456.
13. Goebel, S. J., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179:247-266.
14. Guo, P., S. Goebel, M. E. Perkus, J. Taylor, E. Norton, G. Allen, B. Languet, P. Desmettre, and E. Paoletti. 1990. Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity. J. Virol. 64:2399-2406
15. Herrington, D. A., D. F. Clyde, G. Losonsky, M. Cortesia, J. R. Murphy, J. Davis, S. Baqar, A. M. Felix, E. P. Heimer, D. Gillessen, E. Nardin, R. S. Nussenzweig, M. R. Hollingdale, and M. M. Levine. 1987. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature (London) 328:257-259.
16. Hollingdale, M., F. Zavala, R. Nussenzweig, and V. Nussenzweig. 1982. Antibodies to the protective antigen of Plasmodium berghet sporozoites prevent entry into cultured cells. J. Immunol. 128:1929-1930.
17. Hu, S.-L., S. G. Kosowski, and J. M. Dalrymple. 1986. Expression of AIDS virus envelope gene in recombinant vaccinia viruses. Nature (London) 320:537-540.
18. Khusmith, S., Y. Charoenvit, S. Kumar, M. Sedegah, R. L. Beaudoin, and S. L. Hoffman. 1991. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252:715-718.
19. Konishi, E., S. Pincus, E. Paoletti, R. E. Shope, T. Burrage, and P. W. Mason. 1992. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection Virology 188:714-720.
20. Lal, A. A., V. F. de la Cruz, M. F. Good, W. R. Weiss, M. Lunde, W. Maloy, J. A. Welsh, and T. F. McCutchan. 1987. In vivo testing of subunit vaccines against malaria sporozoites using a iodent system. Proc. Natl. Acad Sci. USA 84:8647-8651.
21. Lanar, D. E. 1990. Sequence of the circumsporozoite gene of Plasmodium berghei ANKA clone and NK65 strain. Mol. Biochem Parasitol. 39:151-154.
22. Langford, C. J., S. J. Edwards, G. L. Smith, G. F. Mitchell, B. Moss, D. J. Kemp, and R. F. Anders. 1086. Anchoring a secreted Plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity. Mol. Cell. Biol 6:3191-3199.
23. + T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA 90:5214-5218.
24. Link, H. T., W. R. Ballou, and U. Krzych. 1990. Immune response to Plasmodium berghei antigens. I. Evaluation of murine T cell repertoire following immunization with irradiated sporozoites. Am J. Trop. Med. Hyg. 43:452-463.
25. Mason, P. W., S. Pincus, M. J. Fournier, T. L. Mason, R. E. Sliope, and E. Paoletti. 1991. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection Virology 180:294-305.
26. Morgan, A. J., M. Mackett, S. Finerty, J. R. Arrand, F. T. Scullion, and M. A. Epstein. 1988. Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomas. J. Med. Virol. 25:189-195.
27. Nussenzweig, V., and R. S. Nussenzweig. 1989. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45:283-334
28. Panicali, D., S. W. Davis, R. L. Weinberg, and E. Paoletti. 1983. Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutimn. Proc. Natl. Acad. Sci. USA 80:5364-5368.
29. Paoletti, E., B. R. Lipinskas, C. Samsonoff, S. Mercer, and D. Panicali. 1984. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proc. Natl Acad. Sci. USA 81:193-197.
30. Perkus, M. E., E. B. Kauffman, J. Taylor, S. Mercer, D. Smith, J. Vander-Hoeven, and E. Paoletti. 1993. Methodology of using vaccinia virus to express foreign genes in tissue culture. J. Tissue Cult. Methods 15:72-81.
31. Perkus, M. E., K. Limbach, and E. Paoletti. 1989. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. J. Virol. 63:3829-3836.
32. Potocnjak, P., N. Yoshida, R. S. Nussenzweig, and V. Nussenzweig. 1980. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Ph44) protect mice against malarial infection. J. Exp. Med. 151:1504-1513.
33. Pye, D., S. J. Edwards, R. F. Anders, C. M. O'Brien, P. Franchina, L. N. Corcoran, C. Monger, M. G. Peterson, K. L. Vandenberg, J. A. Smythe, S. R. Westley, R. L. Coppel, T. L. Webster, D. J. Kemp, A. W. Hampson, and C. J. Langford. 1991. Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria. Infect. Immun. 59:2403-2411.
34. Romero, P., J. L. Maryanski, G. Corradin, R. S. Nussenzweig, V. Nussenzweig, and F. Zavaia. 1989 Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect aganist malaria. Nature (London) 341:323-326.
35. Romero, P., J. P. Tam, D. Schlesinger, P. Clavijo, H. Gibson, P. J. Barr, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala. 1988. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei. Eur J Immunol 18:1951-1957
36. Sadoff, J. C., W. R. Ballou, L. S. Baron, W. R. Majarian, R. N. Brey, W. T. Hockmeyer, J. F. Young, S. J. Cryz, J. Ou, G. H. Lowell, and J. D. Chulay. 1988. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 240:336-338
37. Satchidanandam, V., F. Zavala, and B. Moss. 1991 Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei. Mol. Biochem. Parasitol. 48:89-100.
38. Schodel, F., R. Wirtz, D. Peterson, J. Hughes, R. Warren, J. Sadoff, and D. Milich. 1994. Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes. J. Exp. Med 180:1037-1046.
39. + cells and antibodies required for immunity to malaria sporozoites. Nature (London) 330:664-666.
40. Sedegah, M., R. L. Beaudoin, P. de la Vega, M. F. Leef, M. A. Ozcel, E. Jones, Y. Charoenvit, L. F. Yuan, M. Gross, W. R. Majarian, F. A. Robey, W. Weiss, and S. L. Hoffman. 1988. Use of a vaccinia construct expressing the circumsporozoite protein in the analysis of protective immunity to Plasmodium yoelii UCLA Symp. Mol. Cell. Biol New Ser 84:295-300.
41. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866-9870.
42. + T cells. J. Exp. Med. 180:353-358
43. Smith, G. L., B. R. Murphy, and B. Moss. 1983. Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters Proc Natl. Acad. Sci. USA 80:7155-7159.
44. Tam, J. P., P. Clavijo, Y. A. Lu, V. Nussenzweig, R. Nussenzweig, and F. Zavala. 1990. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 171:299-306.
45. Tartaglia, J., M. E. Perkus, J. Taylor, E. K. Norton, J. C. Audonnet, W. I. Cox, S.W. Davis, J. VanderHoeven, B. Meignier, M. Riviere, B. Languet, and E. Paoletti. 1992. NYVAC: a highly attenuated strain of vaccinia virus. Virology 188:217-232.
46. Tartaglia, J., S. Pincus, and E. Pauletti. 1990. Poxvirus-based vectors as vaccine candidates. Crit. Rev. Immunol. 10:13-30.
47. Taylor, J., J. Tartaglia, T. Moran, R. G. Webster, J.-F. Bouquet, F. W. Quimby, D. Holmes, E. Laplace, T. Mickle, and E. Paoletti. 1992. The role of poxvirus vectors in influenza vaccine development, p 311-335. In Proceedings of the Third International Symposium on Avian Influenza, 1992 University of Wisconsin - Madison.
48. Tine, J. A., V. Conseil, P. Delplace, C. de Taisne, D. Camus, and E. Paoletti. 1993. Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus Infect. Immun. 61:3933-3941.
49. Tine, J. A., D. E. Lanar, D. M. Smith, B. T. Wellde, P. Schultheiss, L. A. Ware, E. B. Kauffman, R. A. Wirtz, C. de Taisne, G. S. N. Hui, S. P. Chang, M. R. Hollingdale, P. Church, D. C. Kaslow, S. Hoffman, K. P. Guito, W. R. Ballon, J. C. Sadoff, and E. Paoletti. NYVAC Pf7: a poxvirus-vectored, multi-antigen, multi-stage vaccine candidate for Plasmodium falciparum malaria. Submitted for publication.
50. Tine, J. A., J. Taylor, and E. Paoletti. 1994. Recent advances in recombinant vaccines for viral and parasitic diseases, p. 121-151. In E. Kurstak (ed.), Modern vaccinology. Plenum Medical. New York
51. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Detective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211-1224.
52. Wachsman, M., L. Aurelian, C. C. Smith, B. R. Lipinskas, M. E. Perkus, and E. Paoletti. 1987. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D. J. Infect. Dis. 155:1188-1197.
53. Weber, J. L., J. E. Egan, J. L. Lyon, R. A. Wirtz, Y. Charoenvit, W. L. Maloy, and W. T. Hockmeyer. 1987. Plasmodium hergheli cloning of the circumsporozoite gene. Exp. Parasitol. 63:295-300
54. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci USA 85:573-576.
55. White, K. L., D. L. Jarboe, and U. Krzych. 1994. Immunization with irradiated Plasmodium berghei sporozoites induces IL-2 and IFNγ4 but not IL-4. Parasite Immunol. 16:479-491.
56. Yewdell, J. W., J. R. Benniuk, G. L. Smith, and B. Moss. 1985. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad Sci. USA 82:1785-1789.
57. Zarting, J. M., W. Morton, P. A. Moran, J. McClure, S. G. Kosowski, and S. L. Hu. 1986. T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses. Nature (London) 323:344-346
58. Zavala, F., A. Cochrane, E. Nardin, R. Nussenzweig, and V. Nussenzweig. 1983. Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J. Exp. Med. 157:1947-1957.
59. Zhao, B., G. Prince, R. Horswood, K. Eckels, P. Summers, R. Chanock, and C. J. Lai. 1987. Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus J Virol. 61:4019-4022.